Skip to main content

Table 2 Intragroup comparison of mean SPO2 of the MAD and CMOA groups

From: Comparative evaluation of the efficacy of customized maxillary oral appliance with mandibular advancement appliance as a treatment modality for moderate obstructive sleep apnea patients—a randomized controlled trial

Groups

Timeline

N

Mean %

S.D.

P-value#

MAD

Baseline

20

85.70

4.47

<0.001†

1 month

20

95.15

1.18

 

1 month

20

95.15

1.18

<0.001†

3 months

20

97.20

1.10

 

Baseline

20

85.70

4.47

<0.001†

3 months

20

97.20

1.10

 

CMOA

Baseline

20

84.95

4.94

<0.001†

1 month

20

94.70

1.92

 

1 month

20

94.70

1.92

<0.001†

3 months

20

96.80

1.23

 

Baseline

20

84.95

4.94

<0.001†

3 months

20

96.80

1.23

 
  1. #P-value derived from independent sample t-test
  2. †Significant at P < 0.05
Back to article page

Trials

ISSN: 1745-6215